{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:13:22Z","timestamp":1793168002023,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.acvd.2023.11.008","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T17:32:05Z","timestamp":1700760725000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of cancer-associated venous thromboembolism in patients under palliative care"],"prefix":"10.1016","volume":"117","author":[{"given":"Philippe","family":"Debourdeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Antoinette","family":"Sevestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bertoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Mayeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Scott\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2023.11.008_bib0160","series-title":"Definition of palliative care","year":"2002"},{"key":"10.1016\/j.acvd.2023.11.008_bib0165","series-title":"Atlas de la fin de vie","year":"2018"},{"key":"10.1016\/j.acvd.2023.11.008_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.2016.70.1474","article-title":"Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice guideline update","volume":"35","author":"Ferrell","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acvd.2023.11.008_bib0175","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221081121","article-title":"Venous thromboembolism in patients with cancer receiving specialist palliative care","volume":"28","author":"Allende-Perez","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.acvd.2023.11.008_bib0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2018.12.028","article-title":"Thromboembolic disease in palliative and end-of-life care: a narrative review","volume":"175","author":"Chin-Yee","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2023.11.008_bib0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1472-6939-13-22","article-title":"The ethical decisions UK doctors make regarding advanced cancer patients at the end of life\u00a0\u2013\u00a0the perceived (in) appropriateness of anticoagulation for venous thromboembolism: a qualitative study","volume":"13","author":"Sheard","year":"2012","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.acvd.2023.11.008_bib0190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acvd.2023.11.008_bib0195","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/S2352-3026(18)30215-1","article-title":"Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study","volume":"6","author":"White","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.acvd.2023.11.008_bib0200","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1200\/JCO.2006.06.5870","article-title":"Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance","volume":"24","author":"O\u2019Connell","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acvd.2023.11.008_bib0205","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/1754-9485.13185","article-title":"Prognostic tools for survival prediction in advanced cancer patients: a systematic review","volume":"65","author":"Pobar","year":"2021","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.acvd.2023.11.008_bib0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/bmj.38733.616065.802","article-title":"Acceptability of low molecular weight heparin thromboprophylaxis for inpatients receiving palliative care: qualitative study","volume":"332","author":"Noble","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2023.11.008_bib0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/0269216305pm1008oa","article-title":"Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study","volume":"19","author":"Noble","year":"2005","journal-title":"Palliat Med"},{"key":"10.1016\/j.acvd.2023.11.008_bib0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/PPA.S79373","article-title":"Patients\u2019 Experiences of LIving with CANcer-associated thrombosis: the PELICAN study","volume":"9","author":"Noble","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.acvd.2023.11.008_bib0225","first-page":"453","article-title":"Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study","volume":"8","author":"Seaman","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.acvd.2023.11.008_bib0230","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.thromres.2020.06.024","article-title":"Patients experience of living with cancer associated thrombosis in France (Le PELICAN)","volume":"194","author":"Mah\u00e9","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2023.11.008_bib0235","first-page":"3233","article-title":"Patients\u2019 Experience of Living with Cancer-associated thrombosis in Spain (PELICANOS)","volume":"26","author":"Font","year":"2018","journal-title":"Supportive Care Cancer"},{"key":"10.1016\/j.acvd.2023.11.008_bib0240","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/rth2.12274","article-title":"Patient Experience of LIving with CANcer-associated thrombosis in Canada (PELICANADA)","volume":"4","author":"Noble","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.008_bib0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2023.05.008","article-title":"Towards optimal use of antithrombotic therapy of people with cancer at the end of life: a research protocol for the development and implementation of the SERENITY shared decision support tool","volume":"228","author":"Goedegebuur","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2023.11.008_bib0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rmr.2019.01.003","article-title":"Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version]","volume":"36","author":"Sanchez","year":"2019","journal-title":"Rev Mal Respi"},{"key":"10.1016\/j.acvd.2023.11.008_bib0255","first-page":"47","article-title":"Anticoagulation for cancer-associated thrombosis at the end of life: review of a case series of 214 patients. 10th World Research Congress of the European Association for Palliative Care (EAPC)","volume":"32","author":"Noble","year":"2018","journal-title":"Palliat Med"},{"key":"10.1016\/j.acvd.2023.11.008_bib0260","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/0269216307080816","article-title":"The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients","volume":"21","author":"Noble","year":"2007","journal-title":"Palliat Med"},{"key":"10.1016\/j.acvd.2023.11.008_bib0265","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/0269216308098803","article-title":"Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary\/ secondary prophylaxis and complications observed under normal clinical practice","volume":"22","author":"Soto-Cardenas","year":"2008","journal-title":"Palliat Med"},{"key":"10.1016\/j.acvd.2023.11.008_bib0270","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/026921639701100407","article-title":"Problems of anticoagulation within a palliative care setting: an audit of hospice patients taking warfarin","volume":"11","author":"Johnson","year":"1997","journal-title":"Palliat Med"},{"key":"10.1016\/j.acvd.2023.11.008_bib0275","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jth.13606","article-title":"Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study","volume":"15","author":"Tardy","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.008_bib0280","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/jpm.2016.0487","article-title":"Prevalence and clinical intentions of antithrombotic therapy on discharge to hospice care","volume":"20","author":"Kowalewska","year":"2017","journal-title":"J Palliat Med"},{"key":"10.1016\/j.acvd.2023.11.008_bib0285","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/026921639701100606","article-title":"How do palliative physicians manage venous thromboembolism?","volume":"11","author":"Johnson","year":"1997","journal-title":"Palliat Med"},{"key":"10.1016\/j.acvd.2023.11.008_bib0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1049909107310142","article-title":"Use of thromboprophylaxis in palliative care patients: a survey among experts in palliative care, oncology, intensive care, and anticoagulation","volume":"25","author":"Kierner","year":"2008","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.acvd.2023.11.008_bib0295","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaccao.2020.06.001","article-title":"Direct oral anticoagulants in patients with active cancer: a systematic review and meta-analysis","volume":"2","author":"Sabatino","year":"2020","journal-title":"JACC Cardiooncol"},{"key":"10.1016\/j.acvd.2023.11.008_bib0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1470-2045(08)70149-9","article-title":"Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis","volume":"9","author":"Noble","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acvd.2023.11.008_bib0305","first-page":"CD001484","article-title":"Graduated compression stockings for prevention of deep vein thrombosis","volume":"11","author":"Sachdeva","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.acvd.2023.11.008_bib0310","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/annonc\/mdx172","article-title":"Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study","volume":"28","author":"Bourgeois","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.acvd.2023.11.008_bib311","article-title":"Anticoagulant treatment of cancer-associated thromboembolism","volume":"117","author":"Mah\u00e9","year":"2024","journal-title":"Arch Cardiovasc Dis"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187521362300517X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187521362300517X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:49:12Z","timestamp":1761745752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187521362300517X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S187521362300517X"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2023.11.008","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of cancer-associated venous thromboembolism in patients under palliative care","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2023.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}